跳至主要内容
临床试验/DRKS00007885
DRKS00007885已完成未知

Safety and efficacy of preoperative sphincter botulinum toxin injection on postoperative pancreatic fistula after distal pancreatectomy

niversitätsklinikum Heidelberg0 个研究点目标入组 29 人开始时间: 2015年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients scheduled for elective distal pancreaectomy for various underlying diseases • Age equal or greater than 18 years • Written informed consent

排除标准

  • Creatinine clearance < 30 mL/min (estimated by Cockcroft-Gault) • Serious cardiovascular disease (e.g. myocardial infarction in the last 12 months, congestive heart failure NYHA III/IV, unstable angina pectoris) • Liver cirrhosis • ASA score > III • Immunosuppressive therapy • Pregnancy or lactation • Understanding or language problems
  • Inability to comply with study and/or follow-up procedures • Known allergy or intolerability to botulinum toxin • Any condition which could result in an undue risk for the patient in the opinion of the investigator

研究者

发起方
niversitätsklinikum Heidelberg

相似试验